学术任务
日期 | 时间 | 会场 | 类型 | Session/单元 | 题目 |
2024-11-16 | 11:20-11:28 | 719阿里山 | 论文发言 | 论文交流-34 | Clinical Efficacy of Anti-programmed Death Ligand 1 Immunotherapy Combined with Chemoradiotherapy in the Treatment of Limited-stage Small Cell Lung Cancer and Its Effect on Serum Tumor Markers and T Lymphocyte Subsets |